Bethesda (1)

BRCA1-Associated Protein-1 (BAP1) Mutations (1)

Early-stage BAP1-associated Malignancies (1)

Early-stage Mesothelioma (1)

Malignant Mesothelioma (MM) (1)

Mesothelioma (1)

Subclinical Mesothelioma (1)

Not yet recruiting (1)

phase 2 (1)

National Cancer Institute (NCI) (1)

decitabine/cedazuridine (1)

drug (1)

NIH (1)

Interventional (1)

subclinical mesothelioma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Aug 1, 2023